Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- Check3 days agoChange DetectedFooter revision label updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check10 days agoChange DetectedThe history page adds a glossary toggle and color-coded indicators for changes (green for additions, red for deletions); the latest revision is v3.4.0 dated 2026-01-22.SummaryDifference0.7%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a new Study Status entry on 2026-01-02 and a new version 68 on 2025-12-30. The 2025-07-18 entry was deleted.SummaryDifference0.2%

- Check46 days agoChange DetectedA new entry Revision: v3.3.3 was added to the record history, and the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed.SummaryDifference0.1%

- Check67 days agoChange DetectedThe change log shows a minor version bump from v3.3.1 to v3.3.2 in the page's revision history, with no impact on visible study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, indicating a system update to the site's history view. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.